Skip to content

Prophylactic antibiotic in patients who undergo cystoscopy with urine sterile: a double blind controlled clinical trial

What is the efficacy of antibiotic (levofloxacin) prophylaxis compared with placebo in patients of both genders aged 18 years and above who are undergoing cystoscopy with sterile urine in decreasing the incidence of urinary tract infection?

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611000750987
Enrollment
300
Registered
2011-07-18
Start date
2012-07-20
Completion date
2012-07-20
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

There will be a double-blind controlled clinical trial Multicentre, with the aim of providing critical information for making decisions regarding the use of antibiotic prophylaxis in patients who undergo outpatient cystoscopy. It makes the next project is to determine for 2011, the effectiveness of antibiotic prophylaxis in patients with sterile urine, will be to establish the incidence of urinary tract infection in each group as the primary outcome variable and determine the possible complications and effects adverse experimental therapy. Will take care of the proper use of the principles of medical ethics such as: justice, beneficence and respect.

Interventions

Intervention group: Prophylactic antibiotic levofloxacin 500 mg orally single dose 30 to 60 minutes before the cystoscopy

Sponsors

Herney Garcia
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients over 18 years, with cystoscopy for any cause, negative urine culture, those who sign in the consent to participate in the study.

Exclusion criteria

Inability to track or allergy to antibiotic use, or interactions with other drugs, with specific indication for prophylaxis (Pe prosthetic heart valve, heart murmur, prosthetic orthopedic or vascular), taking antibiotics at the time of the procedure, who have a permanent urethral catheter, patients with immunosuppression, spinal cord injury that required catheterization, who were let urethral catheter after the procedure (Exclusions post-randomisation).

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026